Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders
Molecular Psychiatry · 2024-07 · 29 (7) · 2021-2030
DOI: 10.1038/s41380-024-02446-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Psychiatry, online erschienen am 15.02.2024. Verfasst von Dora Koller und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. dora.koller@yale.edu. Hauptthemen laut MEDLINE: Chronic Pain, Genome-Wide Association Study, Genetic Pleiotropy, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDCD NIH HHS, NIMH NIH HHS.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Individuals suffering from chronic pain develop substance use disorders (SUDs) more often than others. Understanding the shared genetic influences underlying the comorbidity between chronic pain and SUDs will lead to a greater understanding of their biology. Genome-wide association statistics were obtained from the UK Biobank for multisite chronic pain (MCP, Neffective = 387,649) and from the Million Veteran Program and the Psychiatric Genomics Consortium meta-analyses for alcohol use disorder (AUD, Neffective = 296,974), cannabis use disorder (CanUD, Neffective = 161,053), opioid use disorder (OUD, Neffective = 57,120), and problematic tobacco use (PTU, Neffective = 270,120). SNP-based heritability was estimated for each of the traits and genetic correlation (rg) analyses were performed to assess MCP-SUD pleiotropy. Bidirectional Mendelian Randomization analyses evaluated possible causal relationships. Finally, to identify and characterize individual loci, we performed a genome-wide pleiotropy analysis and a brain-wide analysis using imaging phenotypes available from the UK Biobank. MCP was positively genetically correlated with AUD (rg = 0.26, p = 7.55 × 10-18), CanUD (rg = 0.37, p = 8.21 × 10-37), OUD (rg = 0.20, p = 1.50 × 10-3), and PTU (rg = 0.29, p = 8.53 × 10-12). Although the MR analyses supported bi-directional relationships, MCP had larger effects on AUD (pain-exposure: beta = 0.18, p = 8.21 × 10-4; pain-outcome: beta = 0.07, p = 0.018), CanUD (pain-exposure: beta = 0.58, p = 2.70 × 10-6; pain-outcome: beta = 0.05, p = 0.014) and PTU (pain-exposure: beta = 0.43, p = 4.16 × 10-8; pain-outcome: beta = 0.09, p = 3.05 × 10-6) than the reverse. The genome-wide analysis identified two SNPs pleiotropic between MCP and all SUD investigated: IHO1 rs7652746 (ppleiotropy = 2.69 × 10-8), and CADM2 rs1248857 (ppleiotropy = 1.98 × 10-5). In the brain-wide analysis, rs7652746 was associated with multiple cerebellum and amygdala imaging phenotypes. When analyzing MCP pleiotropy with each SUD separately, we found 25, 22, and 4 pleiotropic variants for AUD, CanUD, and OUD, respectively. To our knowledge, this is the first large-scale study to provide evidence of potential causal relationships and shared genetic mechanisms underlying MCP-SUD comorbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. dora.koller@yale.edu.
- Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA. dora.koller@yale.edu.
- Department of Genetics, Microbiology, and Statistics, Faculty of Biology, University of Barcelona, Catalonia, Spain. dora.koller@yale.edu.
- Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
- Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA.
- NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.
ORCID-Profile: Dora Koller, Eleni Friligkou, Daniel F Levey, Hang Zhou, Alexander S Hatoum, Joseph D Deak, Rachel L Kember, Henry R Kranzler, Emma C Johnson, Murray B Stein, Joel Gelernter, Renato Polimanti
Förderung
- NIA NIH HHS
- NIDCD NIH HHS
- NIMH NIH HHS
- NCATS NIH HHS
- Alzheimer's Association
- U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- NIDA NIH HHS
- EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent…
Zitieren
APA
Koller, D., Friligkou, E., Stiltner, B., Pathak, G. A., Løkhammer, S., Levey, D. F., Zhou, H., Hatoum, A. S., Deak, J. D., Kember, R. L., Treur, J. L., Kranzler, H. R., Johnson, E. C., Stein, M. B., Gelernter, J., & Polimanti, R. (2024). Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders. Molecular Psychiatry, 29(7), 2021-2030. https://doi.org/10.1038/s41380-024-02446-3
Vancouver
Koller D, Friligkou E, Stiltner B, Pathak GA, Løkhammer S, Levey DF, et al. Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders. Molecular Psychiatry. 2024;29(7):2021-2030. doi:10.1038/s41380-024-02446-3
BibTeX
@article{Koller2024,
author = {Koller, Dora and Friligkou, Eleni and Stiltner, Brendan and Pathak, Gita A and Løkhammer, Solveig and Levey, Daniel F and Zhou, Hang and Hatoum, Alexander S and Deak, Joseph D and Kember, Rachel L and Treur, Jorien L and Kranzler, Henry R and Johnson, Emma C and Stein, Murray B and Gelernter, Joel and Polimanti, Renato},
title = {Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders},
journal = {Molecular Psychiatry},
year = {2024},
volume = {29},
number = {7},
pages = {2021--2030},
doi = {10.1038/s41380-024-02446-3}
}
EUVIMED